Photo of Carry Spier
D New Hampshire House · District Hillsborough 6

Rep. Carry Spier

Compare
Total votes
1,038
all sessions
Attendance
98%
25 missed
Higher than 91% of chamber peers
With party
95%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Near the chamber average
Sponsored
28
bills & resolutions
Near the chamber average
Committees
1
assignment
28 bills and resolutions

Sponsored bills

Total
28
Primary
3
Co-sponsor
25
This page
28
matching current filters
Co-sponsor HB 1680
Failed · New Hampshire House · Co-sponsor
relative to intercity bus service and public transportation funding.

Maddy summaryHB 1680 directs New Hampshire's Department of Transportation to improve Boston express bus service from Nashua, Manchester, and Londonderry. It requires increasing service frequency during peak commuting hours and late nights on Fridays/Saturdays, advocating for consistent federal/state funding, and allocating existing federal funds to expand this service. The bill mandates a report on service frequency, ridership, and impacts on workforce mobility and regional economic development, due November 1. Crucially, the bill does not provide new state funding but directs the use of existing transportation program resources.

Failed Mar 5, 2026 1 co-sponsor
Co-sponsor HB 1456
died · New Hampshire House · Co-sponsor
repealing the legislature's declaration of authority over public education.

Maddy summaryHB 1456 repeals a specific legal statement (RSA 2025, 141:389) in New Hampshire law that declared the legislature's authority over public education. This bill removes the legislative declaration itself but does not change how public education is governed, funded, or managed. It directly affects the statutory text of the law by eliminating this declaration, with no new policies or requirements added. The repeal takes effect immediately upon the bill's passage, as specified in the text. This is a procedural change to the law, not a substantive shift in education policy.

died Mar 2, 2026 1 co-sponsor
Co-sponsor HB 1739
Failed · New Hampshire House · Co-sponsor
relative to energy infrastructure, economic development, and workforce training for large-scale data facilities.

Maddy summaryHB 1739 creates incentives to attract large data-center campuses to New Hampshire while modernizing the electric grid. It offers developers phased property tax breaks over 12 years and transferable tax credits covering up to 20% of construction costs, contingent on signing binding Grid Modernization Agreements. These agreements require developers to source non-gas electricity (like solar or wind) matching their energy use, fund grid-stabilizing programs, and partner with community colleges for workforce training in data-center operations. The bill also establishes fast-track permitting for eligible sites and mandates community benefits like noise limits, environmental screening, and resident bill credits from exported power.

Failed Feb 19, 2026 1 co-sponsor
Co-sponsor HB 1198
In committee · New Hampshire House · Co-sponsor
establishing the paint product stewardship program.

Maddy summaryHB 1198 establishes a program to manage paint consumers no longer want (postconsumer paint) by requiring paint manufacturers to create and fund a stewardship plan. The plan must detail how to collect, recycle, or responsibly dispose of unused paint, include a fee added to each paint purchase, and cover consumer education. Manufacturers must submit their approved plans to the state environmental agency within 12 months, and retailers can only sell paint if the manufacturer has an approved plan. This directly affects paint manufacturers, retailers, and voluntary collection sites that participate.

In committee Feb 19, 2026 1 co-sponsor
Co-sponsor HB 648
In committee · New Hampshire House · Co-sponsor
relative to insurance coverage for glucose monitoring.

Maddy summaryHB 648 proposes to require health insurance plans to cover glucose monitoring devices for individuals with diabetes. The bill would mandate coverage for necessary monitoring equipment, directly affecting policyholders with diabetes and their insurers. Currently pending in committee with a referral for interim study (as of November 13, 2025), the bill has not yet been enacted. Specific coverage details or device types are not provided in the available context.

In committee Nov 13, 2025 1 co-sponsor
Co-sponsor SB 247
Passed · New Hampshire Senate · Co-sponsor
prohibiting network exclusion for pharmacies that refuse to dispense a prescription of the PBM reimbursement that is below the pharmacy's acquisition cost.

Maddy summarySenate Bill 247 modifies regulations for contracts between health carriers, pharmacy benefit managers (PBMs), and pharmacies. It requires PBMs and carriers to provide more transparency regarding drug reimbursement calculations, known as Maximum Allowable Cost (MAC) pricing, and establishes a formal appeal process for pharmacies to dispute these costs. The bill also allows pharmacies to decline to dispense a drug if the reimbursement amount is less than their acquisition cost. Additionally, it mandates that Pharmacy Services Administrative Organizations (PSAOs) provide pharmacies with copies of PBM contracts and prohibits them from requiring pharmacies to purchase drugs from specific entities. These provisions are set to take effect on January 1, 2026.

Passed Nov 13, 2025 1 co-sponsor
Co-sponsor HB 604
In committee · New Hampshire House · Co-sponsor
relative to a loan forgiveness program for low-income homeowners to build new accessory dwelling units or renovate existing structures into accessory dwelling units.

Maddy summaryHB 604 would create a loan forgiveness program for low-income homeowners who build new accessory dwelling units (ADUs) or convert existing structures (like garages) into ADUs. It directly affects qualifying low-income homeowners in the state by covering the cost of their loans for these projects, reducing financial barriers. The key mechanism is that approved homeowners would not need to repay the loan after completing the ADU construction or renovation. This policy aims to increase housing options through secondary units without requiring repayment from eligible residents.

In committee Nov 12, 2025 1 co-sponsor
Primary HB 297
In committee · New Hampshire House · Lead sponsor
relative to providing self-funded employer health benefit plans access to their claims data.

Maddy summaryHB 297 allows self-funded employers (those managing their own health insurance without a traditional insurer) to access annual reports of their health plan's claims data. Employers must opt in in writing to receive these de-identified, aggregated reports from health insurers or third-party administrators. Insurers must annually notify employers about this option, explaining privacy protections and the benefits of participating. The bill does not require employers to report data or change how their health plans are administered.

In committee Nov 10, 2025 0 co-sponsors
Co-sponsor HB 580
In committee · New Hampshire House · Co-sponsor
relative to retaliatory defamation in domestic violence and sexual violence cases.

Maddy summaryHB 580 addresses retaliatory defamation claims in domestic violence and sexual violence cases. The bill's title indicates it aims to prevent defendants from using defamation lawsuits as a tactic to retaliate against victims who report abuse. However, the provided context does not include the bill's specific provisions or policy mechanisms. The bill has been referred for interim study (Committee Report: 09/10/2025, Vote 15-0) and remains pending in committee as of the latest action. No concrete policy changes or affected parties are described in the given context.

In committee Nov 4, 2025 1 co-sponsor
Co-sponsor HB 117
Signed into law · New Hampshire House · Co-sponsor
relative to the substitution of biological products.

Maddy summaryThis bill defines key terms for substituting biological products (like insulin or cancer treatments made from living organisms) in New Hampshire. It specifies that a "biosimilar" is a product highly similar to an original with no meaningful differences in safety or effectiveness, and an "interchangeable" product meets federal standards for safe substitution without requiring a doctor's specific order. These definitions will guide pharmacists when replacing a prescribed biological product with a biosimilar or interchangeable alternative. The bill directly affects pharmacists, healthcare providers, and patients by establishing a clear legal framework for substitution, aligning with federal guidelines.

Signed into law Jul 22, 2025 1 co-sponsor
Showing 11 to 20 of 28 bills